Related Experiment Video

Updated: May 20, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

PI3Kδ is essential for tumor clearance mediated by cytotoxic T lymphocytes

Eva Maria Putz1, Michaela Prchal-Murphy, Olivia Annabella Simma

  • 1Department for Biomedical Sciences, Institute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, Vienna, Austria. eva-maria.zebedin@meduniwien.ac.at

Plos One
|July 19, 2012
PubMed
Abstract

Insights

Phosphoinositide 3-kinase delta (PI3Kδ) is crucial for cytotoxic T lymphocyte (CTL) function in tumor surveillance. Inhibiting PI3Kδ impairs CTLs, potentially limiting long-term cancer treatment effectiveness.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Phosphoinositide 3-kinase delta (PI3Kδ) is a lipid kinase vital for leukocyte signaling, proliferation, differentiation, and survival.
  • PI3Kδ inhibitors are being investigated for hematopoietic malignancies, but PI3Kδ is also essential for immune cell function.
  • Cytotoxic T lymphocytes (CTLs) are critical for tumor surveillance, making their function under PI3Kδ inhibition a key area of study.

Purpose of the Study:

  • To investigate the impact of PI3Kδ inhibition on CTL function.
  • To clarify the role of PI3Kδ in CTL-mediated tumor surveillance.

Main Methods:

  • Studied PI3Kδ-deficient mice challenged with MC38 colon adenocarcinoma cells.
  • Assessed CTL-mediated cytotoxicity in vitro and in vivo.
  • Analyzed mRNA levels of cytotoxic machinery components (prf1, grzmA, grzmB, fasl, trail).
  • Characterized tumor-infiltrating CTL phenotype (CD69, CD62L) and degranulation using electrophysiological capacitance measurements.

Main Results:

  • PI3Kδ-deficient mice exhibited significantly larger tumors, indicating impaired tumor surveillance.
  • Absence of PI3Kδ severely diminished CTL cytotoxicity via both perforin-granzyme and death-receptor pathways.
  • PI3Kδ-deficient CTLs showed reduced mRNA expression of key cytotoxic molecules and a naive T cell phenotype.
  • A fundamental degranulation defect was confirmed in PI3Kδ-deficient CTLs.

Conclusions:

  • CTL-mediated tumor surveillance is significantly impaired without PI3Kδ.
  • Impaired immunosurveillance due to PI3Kδ inhibition may limit the efficacy of long-term PI3Kδ inhibitor treatment.

More Related Videos

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity06:16

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Published on: December 7, 2019

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...